ID

44548

Description

Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium; ODM derived from: https://clinicaltrials.gov/show/NCT02003339

Link

https://clinicaltrials.gov/show/NCT02003339

Keywords

Versions (2)
  1. 2/23/20 2/23/20 -
  2. 9/27/21 9/27/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 27, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatocellular Carcinoma NCT02003339

English

Eligibility Hepatocellular Carcinoma NCT02003339

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
early, intermediate, advanced, non metastatic hepatocellular carcinoma. indication for radioembolization validated after pluridisciplinary committee meeting.
Description

Early Hepatocellular Carcinoma | Liver carcinoma Intermediate | Liver carcinoma Advanced | Liver carcinoma Without Metastasis | Indication Radioembolisation

Data type

boolean

Alias
UMLS CUI [1]
C3273019
UMLS CUI [2,1]
C2239176
UMLS CUI [2,2]
C0205103
UMLS CUI [3,1]
C2239176
UMLS CUI [3,2]
C0205179
UMLS CUI [4,1]
C2239176
UMLS CUI [4,2]
C0332288
UMLS CUI [4,3]
C0027627
UMLS CUI [5,1]
C3146298
UMLS CUI [5,2]
C2985560
isolated target on initial imagery (invasive hepatocellular carcinoma excluded)
Description

Target Isolated Imaging | Liver carcinoma Invasive Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C1521840
UMLS CUI [1,2]
C0205409
UMLS CUI [1,3]
C0011923
UMLS CUI [2,1]
C2239176
UMLS CUI [2,2]
C0205281
UMLS CUI [2,3]
C0332196
who (world health organization) performance status: 0, 1 or 2
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
if cirrhosis, child a score with total bilirubin less than 30 micromoles per liter
Description

Liver Cirrhosis Child-Pugh Classification | Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C4050412
UMLS CUI [2]
C1278039
creatinine clearance more or equal to 30 ml/min
Description

Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0373595
patient informed and consent signature obtained
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
invasive hepatocellular carcinoma without any isolated tumor
Description

Liver carcinoma Invasive | Absence Tumor Isolated

Data type

boolean

Alias
UMLS CUI [1,1]
C2239176
UMLS CUI [1,2]
C0205281
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0027651
UMLS CUI [2,3]
C0205409
disease needing 2 injections of therasphere
Description

Requirement Therasphere Injection Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1514873
UMLS CUI [1,2]
C1135147
UMLS CUI [1,3]
C1828121
UMLS CUI [1,4]
C1265611
thrombosis extending into the porta(thrombosis of one of left or right branch authorized), extra hepatic metastasis
Description

Thrombosis Extending Porta hepatis | Thrombosis Left branch of portal vein | Thrombosis Right branch of portal vein | Neoplasm Metastasis Extrahepatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0040053
UMLS CUI [1,2]
C0439792
UMLS CUI [1,3]
C0227498
UMLS CUI [2,1]
C0040053
UMLS CUI [2,2]
C0226731
UMLS CUI [3,1]
C0040053
UMLS CUI [3,2]
C0226730
UMLS CUI [4,1]
C0027627
UMLS CUI [4,2]
C1517058
previous treatment by chemoembolization, radiofrequency less than 3 months before radioembolization
Description

Chemoembolization | Radiofrequency

Data type

boolean

Alias
UMLS CUI [1]
C0796679
UMLS CUI [2]
C0579006
no antiangiogenic concomitant treatment, 15 days before and 15 days after radioembolization, including sorafenib
Description

Antiangiogenic therapy

Data type

boolean

Alias
UMLS CUI [1]
C2363719
associated disease which could prevent patient from receiving treatment
Description

Comorbidity Preventing Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C1292733
UMLS CUI [1,3]
C0087111
rmi contre-indication(particle or metal prosthesis, pacemaker, claustrophobia) or contrast product contre-indication (allergy)
Description

Medical contraindication MRI | Metallic implant | Pacemaker | Claustrophobia | Contrast media allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0024485
UMLS CUI [2]
C3693688
UMLS CUI [3]
C0810633
UMLS CUI [4]
C0008909
UMLS CUI [5]
C0570562
patient already participating in an other therapeutic trial with an experimental drug
Description

Study Subject Participation Status | Therapy, Investigational | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0949266
UMLS CUI [3]
C0013230
pregnant or childbearing potential women or breastfeeding women
Description

Pregnancy | Childbearing Potential | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C3831118
UMLS CUI [3]
C0006147
minors, persons deprived of liberty or protected adults (maintenance of justice, guardianship or supervision) unable to comply with trial medical follow-up for geographical, social or psychological reasons
Description

Minors | Persons Deprivation Freedom | Guardianship of person | Compliance behavior Unable Clinical Study Follow-up

Data type

boolean

Alias
UMLS CUI [1]
C0026193
UMLS CUI [2,1]
C0027361
UMLS CUI [2,2]
C0871712
UMLS CUI [2,3]
C0016694
UMLS CUI [3]
C0680611
UMLS CUI [4,1]
C1321605
UMLS CUI [4,2]
C1299582
UMLS CUI [4,3]
C3274571
unable to sign an informed consent
Description

Informed Consent Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
Back to the top of the page

Similar models

Eligibility Hepatocellular Carcinoma NCT02003339

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Early Hepatocellular Carcinoma | Liver carcinoma Intermediate | Liver carcinoma Advanced | Liver carcinoma Without Metastasis | Indication Radioembolisation
Item
early, intermediate, advanced, non metastatic hepatocellular carcinoma. indication for radioembolization validated after pluridisciplinary committee meeting.
boolean
C3273019 (UMLS CUI [1])
C2239176 (UMLS CUI [2,1])
C0205103 (UMLS CUI [2,2])
C2239176 (UMLS CUI [3,1])
C0205179 (UMLS CUI [3,2])
C2239176 (UMLS CUI [4,1])
C0332288 (UMLS CUI [4,2])
C0027627 (UMLS CUI [4,3])
C3146298 (UMLS CUI [5,1])
C2985560 (UMLS CUI [5,2])
Target Isolated Imaging | Liver carcinoma Invasive Excluded
Item
isolated target on initial imagery (invasive hepatocellular carcinoma excluded)
boolean
C1521840 (UMLS CUI [1,1])
C0205409 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
C2239176 (UMLS CUI [2,1])
C0205281 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
WHO performance status scale
Item
who (world health organization) performance status: 0, 1 or 2
boolean
C1298650 (UMLS CUI [1])
Liver Cirrhosis Child-Pugh Classification | Serum total bilirubin measurement
Item
if cirrhosis, child a score with total bilirubin less than 30 micromoles per liter
boolean
C0023890 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
C1278039 (UMLS CUI [2])
Creatinine clearance measurement
Item
creatinine clearance more or equal to 30 ml/min
boolean
C0373595 (UMLS CUI [1])
Informed Consent
Item
patient informed and consent signature obtained
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Liver carcinoma Invasive | Absence Tumor Isolated
Item
invasive hepatocellular carcinoma without any isolated tumor
boolean
C2239176 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C0027651 (UMLS CUI [2,2])
C0205409 (UMLS CUI [2,3])
Requirement Therasphere Injection Quantity
Item
disease needing 2 injections of therasphere
boolean
C1514873 (UMLS CUI [1,1])
C1135147 (UMLS CUI [1,2])
C1828121 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Thrombosis Extending Porta hepatis | Thrombosis Left branch of portal vein | Thrombosis Right branch of portal vein | Neoplasm Metastasis Extrahepatic
Item
thrombosis extending into the porta(thrombosis of one of left or right branch authorized), extra hepatic metastasis
boolean
C0040053 (UMLS CUI [1,1])
C0439792 (UMLS CUI [1,2])
C0227498 (UMLS CUI [1,3])
C0040053 (UMLS CUI [2,1])
C0226731 (UMLS CUI [2,2])
C0040053 (UMLS CUI [3,1])
C0226730 (UMLS CUI [3,2])
C0027627 (UMLS CUI [4,1])
C1517058 (UMLS CUI [4,2])
Chemoembolization | Radiofrequency
Item
previous treatment by chemoembolization, radiofrequency less than 3 months before radioembolization
boolean
C0796679 (UMLS CUI [1])
C0579006 (UMLS CUI [2])
Antiangiogenic therapy
Item
no antiangiogenic concomitant treatment, 15 days before and 15 days after radioembolization, including sorafenib
boolean
C2363719 (UMLS CUI [1])
Comorbidity Preventing Therapeutic procedure
Item
associated disease which could prevent patient from receiving treatment
boolean
C0009488 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
Medical contraindication MRI | Metallic implant | Pacemaker | Claustrophobia | Contrast media allergy
Item
rmi contre-indication(particle or metal prosthesis, pacemaker, claustrophobia) or contrast product contre-indication (allergy)
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C3693688 (UMLS CUI [2])
C0810633 (UMLS CUI [3])
C0008909 (UMLS CUI [4])
C0570562 (UMLS CUI [5])
Study Subject Participation Status | Therapy, Investigational | Investigational New Drugs
Item
patient already participating in an other therapeutic trial with an experimental drug
boolean
C2348568 (UMLS CUI [1])
C0949266 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
Pregnancy | Childbearing Potential | Breast Feeding
Item
pregnant or childbearing potential women or breastfeeding women
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Minors | Persons Deprivation Freedom | Guardianship of person | Compliance behavior Unable Clinical Study Follow-up
Item
minors, persons deprived of liberty or protected adults (maintenance of justice, guardianship or supervision) unable to comply with trial medical follow-up for geographical, social or psychological reasons
boolean
C0026193 (UMLS CUI [1])
C0027361 (UMLS CUI [2,1])
C0871712 (UMLS CUI [2,2])
C0016694 (UMLS CUI [2,3])
C0680611 (UMLS CUI [3])
C1321605 (UMLS CUI [4,1])
C1299582 (UMLS CUI [4,2])
C3274571 (UMLS CUI [4,3])
Informed Consent Unable
Item
unable to sign an informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial